CAS: 57781-14-3; [2-[(6R,8S,9R,10S,11S,13S,14S,17R)-17-Acetyloxy-2-Bromo-6,9-Difluoro-11-Hydroxy-10,13-Dimethyl-3-Oxo-6,7,8,11,12,14,15,16-Octahydrocyclopenta[a]Phenanthren-17-Yl]-2-Oxoethyl] Acetate

该化合物是一种具有抗炎和免疫抑制特性的合成可口可乐类甲状腺,主要用于治疗各种皮肤病,包括乙酰胺和皮丝虫病,以及其他炎性疾病; 复合功能,阻止释放煽动性调节器和调制免疫反应; 甲状腺素的特点是能够有效穿透皮肤,使其适合时尚配方; 通常以药膏或奶油形式提供,允许局部进行局部系统吸收的治疗; 甲状腺素的化学结构包括一种类固醇骨,这是在甲状腺类甲状腺中常见的,造成其致病效应; 与其他可口可口可乐性甲状腺素一样,其使用可能与潜在的副作用有关,特别是长期使用,如皮肤减瘦或系统吸收导致肾上腺抑制. 因此,必须在医疗监督下使用这种药物,以确保安全和功效.

结构式图片

MSDS等安全信息

    上下游产品

    6Beta,9-Difluoro-11Beta,17,21-Trihydroxypregna-1,4-Diene-3,20-Dione 17,21-Di(Acetate) 60864-46-2

    合成工艺路线路线简述

      📜[2-[(6R,8S,9R,10S,13S,14S,17R)-17-Acetyloxy-2-Bromo-6,9-Difluoro-10,13-Dimethyl-3,11-Dioxo-7,8,12,14,15,16-Hexahydro-6H-Cyclopenta[a]Phenanthren-17-Yl]-2-Oxoethyl] Acetate 反应生成 醋酸卤泼尼松
      参考文献:Takagaki,Hidetsugu;Abe,Masayoshi;Watanabe,Michihiro;Takeuchi,Kazuyuki+
      标题:Takagaki,Hidetsugu;Abe,Masayoshi;Watanabe,Michihiro;Takeuchi,Kazuyuki+

      海关参考信息

      专利信息


      专利号:US-2013035307-A1
      优先权日:2010-01-26
      标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
      发明人:PRESTWICH GLENN D; KENNEDY THOMAS P
      权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P
      摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.

      专利号:US-2024287041-A1
      优先权日:2021-05-20
      标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
      发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

      专利号:WO-2023096715-A9
      优先权日:2021-10-22
      标 题:Immunomodulatory glycosphingolipids and methods of use thereof
      发明人:KASPER DENNIS; OH SUNGWHAN
      权利人:HARVARD COLLEGE
      摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

      专利号:WO-2022246227-A1
      优先权日:2021-05-20
      标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

      专利号:US-2022125838-A1
      优先权日:2019-02-11
      标题 :Immunomodulatory glycosphingolipids and methods of use thereof
      发明人:OH SUNGWHAN; KASPER DENNIS L; SONG HEEBUM; PARK SEUNG BUM
      权利人:HARVARD COLLEGE; SEOUL NAT UNIV R&DB FOUNDATION
      摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.

      专利号:US-9907753-B2
      优先权日:2010-03-19
      标 题 :Lipid vesicle compositions and methods of use
      发明人:IRVINE DARRELL J; MOON JAEHYUN
      权利人:MASSACHUSETTS INST TECHNOLOGY
      摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献

      1. Bianchetti A, Bossoni G, Guarneri L, Giudici L, Riva M. Pharmacology of halopredone acetate, a new topical antiinflammatory steroid. Arzneimittelforschung. 1977;27(11):2096-102.

      合成参考文献


      摘要:Mizushima Y, Miyake H, Fujiwara K, Ono N, Takikawa K. A highly topically active corticosteroid. Preliminary report. Arzneimittelforschung. 1980;30(2):274–5.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知